Investors are making a dash for exits after a streak of record-setting days as the pandemic drags on
Albert Bourla, CEO of Pfizer, testifies before the Senate Finance Committee on “Drug Pricing in America: A Prescription for Change, Part II” February 26, 2019 in Washington. Win McNamee/Getty Images … Read More
![]()

